EKBAX
Price
$12.90
Change
+$0.01 (+0.08%)
Updated
May 9 closing price
Net Assets
1.39B
IFAFX
Price
$25.38
Change
+$0.04 (+0.16%)
Updated
May 9 closing price
Net Assets
128.03B
Ad is loading...

EKBAX vs IFAFX

Header iconEKBAX vs IFAFX Comparison
Open Charts EKBAX vs IFAFXBanner chart's image
Allspring Diversified Cap Bldr A
Price$12.90
Change+$0.01 (+0.08%)
VolumeN/A
Net Assets1.39B
American Funds Income Fund of Amer F1
Price$25.38
Change+$0.04 (+0.16%)
VolumeN/A
Net Assets128.03B
EKBAX vs IFAFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EKBAX vs. IFAFX commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKBAX is a Buy and IFAFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
IFAFX has more cash in the bank: 128B vs. EKBAX (1.39B). IFAFX pays higher dividends than EKBAX: IFAFX (3.81) vs EKBAX (0.60). EKBAX was incepted earlier than IFAFX: EKBAX (27 years) vs IFAFX (24 years). EKBAX (1.08) is less costly to investors than IFAFX (0.65). IFAFX is a more actively managed with annual turnover of: 92.00 vs. EKBAX (30.00). IFAFX has a lower initial minimum investment than EKBAX: IFAFX (250) vs EKBAX (1000). IFAFX annual gain was more profitable for investors over the last year : 9.62 vs. EKBAX (-1.26). IFAFX return over 5 years is better than : 40.94 vs. EKBAX (36.50).
EKBAXIFAFXEKBAX / IFAFX
Total Expense Ratio1.080.65166%
Annual Report Gross Expense Ratio1.080.65166%
Fund Existence27 years24 years-
Gain YTD-5.3524.995-107%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.39B128B1%
Annual Yield % from dividends0.603.8116%
Returns for 1 year-1.269.62-13%
Returns for 3 years13.8515.9587%
Returns for 5 years36.5040.9489%
Returns for 10 years40.2335.84112%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGMT3.260.06
+1.87%
Sagimet Biosciences
RGLS7.870.02
+0.25%
Regulus Therapeutics
ESTC85.56-0.71
-0.82%
Elastic NV
PJT144.26-2.26
-1.54%
PJT Partners
ZVSA0.53-0.04
-7.70%
ZyVersa Therapeutics